Delivery Order SPE2DB22D9353-SPE2DB25FX2FX
Award Date 9/26/25
Potential Completion Date 10/20/25
Potential Value $1.6K
Federal Agency
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Park Ridge, IL 60068, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,654.44 to DMS Pharmaceutical Group Inc. on September 26, 2025, for the supply of Tissueblue 0.025% syringes in 0.5ml quantities. This firm fixed-price delivery order is scheduled for ultimate completion by October 20, 2025, with fulfillment from the vendor's location in Park Ridge, Illinois. The award did not utilize a set-aside designation, allowing DMS Pharmaceutical Group to compete on an unrestricted basis despite its...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a firm fixed-price delivery order valued at $1,654.44 by the Defense Logistics Agency on July 16, 2025, for the supply of TissueBlue 0.025% syringes in 0.5mL quantities. The contract carries an ultimate completion date of August 6, 2025, and was performed at the awardee's location in Park Ridge, Illinois. This delivery order was issued without set-aside designation,...
- On August 19, 2025, the Defense Logistics Agency (DLA) awarded a delivery order valued at $1,654.44 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The delivery order is for TissueBlue 0.025% syringes in 0.5mL quantities, with an ultimate completion date of September 10, 2025. This award utilizes a firm fixed-price contract structure with no set-aside designation, and performance will take place at the contractor's...
- The U.S. Defense Logistics Agency (DLA) awarded a firm-fixed-price delivery order contract valued at $4,013.70 to DMS Pharmaceutical Group Inc., a woman-owned small business based in Park Ridge, Illinois. The contract is for the delivery of 0.5 mL syringes containing 0.025% Tissue Blue solution. This order is issued against DMS Pharmaceutical's indefinite delivery contract SPE2DB valued at up to $4,999,999 through 2025, which enables DLA to procure a broad range of pharmaceutical products for...
- On August 18, 2025, the Defense Logistics Agency, operating under the Medical Supply Chain division, awarded a delivery order valued at $1,654.44 to DMS Pharmaceutical Group Inc. for TISSUEBLUE 0.025% Syringe 0.5ML. This firm fixed-price delivery order, with an ultimate completion date of September 9, 2025, was issued without a set-aside designation. DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler headquartered in Park Ridge, Illinois, will perform the...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a firm fixed-price delivery order valued at $4,136.10 by the Defense Logistics Agency (DLA) on August 25, 2025. The contract calls for delivery of TissueBlue 0.025% Syringe 0.5ML, a pharmaceutical product to be delivered to Park Ridge, Illinois, with an ultimate completion date of September 16, 2025. This delivery order was issued without a set-aside designation,...
- The U.S. Defense Logistics Agency (DLA) awarded a firm fixed-price delivery order contract valued at $3,210.96 to DMS Pharmaceutical Group Inc., a woman-owned small business based in Park Ridge, Illinois. The contract is for the delivery of TISSUEBLUE 0.025% SYRINGE 0.5ML, a specialized pharmaceutical product, with a period of performance through December 20, 2024. This award is part of a larger $499,999,999 Indefinite Delivery Contract (IDC) held by DMS Pharmaceutical Group with the DLA under...
- This federal contract award, valued at $1,654.44, was issued by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business. The contract is for the delivery of TISSUEBLUE 0.025% SYRINGE 0.5ML, a medical product, with an ultimate completion date of August 6, 2025. The contract is a firm fixed-price delivery order, and there was no set-aside used. DMS Pharmaceutical Group Inc. is a pharmaceutical wholesaler based in Park Ridge, Illinois, that specializes in...
- This is a firm fixed-price delivery order contract awarded to DMS Pharmaceutical Group Inc., a woman-owned small business, by the Defense Logistics Agency (DLA). The contract is for the supply of TISSUEBLUE 0.025% SYRINGE 0.5ML, a pharmaceutical product, with a ceiling value of $3,308.88 and an ultimate completion date of July 7, 2025. DMS Pharmaceutical Group Inc. is a pharmaceutical wholesaler based in Park Ridge, Illinois, that specializes in providing a range of pharmaceutical products to...
- The Defense Logistics Agency (DLA) awarded a firm fixed-price delivery order contract to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract, valued at $4,136.10, is for the supply of a specific pharmaceutical product - TISSUEBLUE 0.025% SYRINGE 0.5ML. This delivery order is part of a larger $499,999,999 Indefinite Delivery Contract (IDC) held by DMS Pharmaceutical Group with the DLA under the SPE2DB program. The IDC...